medical price control in Pakistan

In Pakistan, the government controls the prices of all drugs, so that more people can afford medicine. For the local manufacture

MDIs, the price in Pakistan is the lowest in the region. If local production exit, this artificial cost

It is impossible to sustain. Therefore, the project intends to support through public education and awareness-raising activities to help manufacturers turn

HFA technology; the use of technical workshops and seminars on building businesses and ozone institutional capacity; develop and implement without

CFC metered-dose inhalers fast track through the system; and to assist in the development of CFC-January 1, 2010 after the need to use

Uses the application process. Transition strategy cost is estimated at $ 181,000

Replace the existing production line with a Macromat filling line and associated pressure filling and preparation tank, and Save

Less conventional areas to GSK-out company for the manufacture of albuterol of 82.6 ODP tonnes of CFCs

Carbon (According to the 2006 MDI production quantity calculation), total cost of $ 1,820,500 (not

Discounting including foreign ownership portion caused). According to one-year period and calculated production of 2006

Incremental operating costs are estimated at $ 2,329,997. Not included on the development of a hydrofluorocarbon alkyl - albuterol meter

The suction applications, because these costs will be paid by GSK;

(